Global Pneumonia Market Growth (Status and Outlook) 2024-2030

September 2024 | 81 pages | ID: G36CFE8DAF95EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Pneumonia market size was valued at US$ million in 2023. With growing demand in downstream market, the Pneumonia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Pneumonia market. Pneumonia are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pneumonia. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pneumonia market.

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.

Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.

Key Features:

The report on Pneumonia market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Pneumonia market. It may include historical data, market segmentation by Type (e.g., Drugs, Vaccines), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pneumonia market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Pneumonia market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Pneumonia industry. This include advancements in Pneumonia technology, Pneumonia new entrants, Pneumonia new investment, and other innovations that are shaping the future of Pneumonia.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pneumonia market. It includes factors influencing customer ' purchasing decisions, preferences for Pneumonia product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pneumonia market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pneumonia market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pneumonia market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pneumonia industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pneumonia market.

Market Segmentation:

Pneumonia market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Drugs
  • Vaccines
  • Oxygen Therapy
Segmentation by application
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • GlaxoSmithKline(GSK)
  • Merck
  • Novartis
  • Sanofi
  • Eli Lilly
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pneumonia Market Size 2019-2030
  2.1.2 Pneumonia Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pneumonia Segment by Type
  2.2.1 Drugs
  2.2.2 Vaccines
  2.2.3 Oxygen Therapy
2.3 Pneumonia Market Size by Type
  2.3.1 Pneumonia Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Pneumonia Market Size Market Share by Type (2019-2024)
2.4 Pneumonia Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Centers
  2.4.3 Others
2.5 Pneumonia Market Size by Application
  2.5.1 Pneumonia Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Pneumonia Market Size Market Share by Application (2019-2024)

3 PNEUMONIA MARKET SIZE BY PLAYER

3.1 Pneumonia Market Size Market Share by Players
  3.1.1 Global Pneumonia Revenue by Players (2019-2024)
  3.1.2 Global Pneumonia Revenue Market Share by Players (2019-2024)
3.2 Global Pneumonia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PNEUMONIA BY REGIONS

4.1 Pneumonia Market Size by Regions (2019-2024)
4.2 Americas Pneumonia Market Size Growth (2019-2024)
4.3 APAC Pneumonia Market Size Growth (2019-2024)
4.4 Europe Pneumonia Market Size Growth (2019-2024)
4.5 Middle East & Africa Pneumonia Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Pneumonia Market Size by Country (2019-2024)
5.2 Americas Pneumonia Market Size by Type (2019-2024)
5.3 Americas Pneumonia Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pneumonia Market Size by Region (2019-2024)
6.2 APAC Pneumonia Market Size by Type (2019-2024)
6.3 APAC Pneumonia Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pneumonia by Country (2019-2024)
7.2 Europe Pneumonia Market Size by Type (2019-2024)
7.3 Europe Pneumonia Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pneumonia by Region (2019-2024)
8.2 Middle East & Africa Pneumonia Market Size by Type (2019-2024)
8.3 Middle East & Africa Pneumonia Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PNEUMONIA MARKET FORECAST

10.1 Global Pneumonia Forecast by Regions (2025-2030)
  10.1.1 Global Pneumonia Forecast by Regions (2025-2030)
  10.1.2 Americas Pneumonia Forecast
  10.1.3 APAC Pneumonia Forecast
  10.1.4 Europe Pneumonia Forecast
  10.1.5 Middle East & Africa Pneumonia Forecast
10.2 Americas Pneumonia Forecast by Country (2025-2030)
  10.2.1 United States Pneumonia Market Forecast
  10.2.2 Canada Pneumonia Market Forecast
  10.2.3 Mexico Pneumonia Market Forecast
  10.2.4 Brazil Pneumonia Market Forecast
10.3 APAC Pneumonia Forecast by Region (2025-2030)
  10.3.1 China Pneumonia Market Forecast
  10.3.2 Japan Pneumonia Market Forecast
  10.3.3 Korea Pneumonia Market Forecast
  10.3.4 Southeast Asia Pneumonia Market Forecast
  10.3.5 India Pneumonia Market Forecast
  10.3.6 Australia Pneumonia Market Forecast
10.4 Europe Pneumonia Forecast by Country (2025-2030)
  10.4.1 Germany Pneumonia Market Forecast
  10.4.2 France Pneumonia Market Forecast
  10.4.3 UK Pneumonia Market Forecast
  10.4.4 Italy Pneumonia Market Forecast
  10.4.5 Russia Pneumonia Market Forecast
10.5 Middle East & Africa Pneumonia Forecast by Region (2025-2030)
  10.5.1 Egypt Pneumonia Market Forecast
  10.5.2 South Africa Pneumonia Market Forecast
  10.5.3 Israel Pneumonia Market Forecast
  10.5.4 Turkey Pneumonia Market Forecast
  10.5.5 GCC Countries Pneumonia Market Forecast
10.6 Global Pneumonia Forecast by Type (2025-2030)
10.7 Global Pneumonia Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Pneumonia Product Offered
  11.1.3 Pfizer Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 GlaxoSmithKline(GSK)
  11.2.1 GlaxoSmithKline(GSK) Company Information
  11.2.2 GlaxoSmithKline(GSK) Pneumonia Product Offered
  11.2.3 GlaxoSmithKline(GSK) Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 GlaxoSmithKline(GSK) Main Business Overview
  11.2.5 GlaxoSmithKline(GSK) Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Pneumonia Product Offered
  11.3.3 Merck Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Pneumonia Product Offered
  11.4.3 Novartis Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Pneumonia Product Offered
  11.5.3 Sanofi Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Eli Lilly
  11.6.1 Eli Lilly Company Information
  11.6.2 Eli Lilly Pneumonia Product Offered
  11.6.3 Eli Lilly Pneumonia Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Eli Lilly Main Business Overview
  11.6.5 Eli Lilly Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Pneumonia Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drugs
Table 3. Major Players of Vaccines
Table 4. Major Players of Oxygen Therapy
Table 5. Pneumonia Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Pneumonia Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Pneumonia Market Size Market Share by Type (2019-2024)
Table 8. Pneumonia Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Pneumonia Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Pneumonia Market Size Market Share by Application (2019-2024)
Table 11. Global Pneumonia Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Pneumonia Revenue Market Share by Player (2019-2024)
Table 13. Pneumonia Key Players Head office and Products Offered
Table 14. Pneumonia Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pneumonia Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Pneumonia Market Size Market Share by Regions (2019-2024)
Table 19. Global Pneumonia Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Pneumonia Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Pneumonia Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Pneumonia Market Size Market Share by Country (2019-2024)
Table 23. Americas Pneumonia Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Pneumonia Market Size Market Share by Type (2019-2024)
Table 25. Americas Pneumonia Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Pneumonia Market Size Market Share by Application (2019-2024)
Table 27. APAC Pneumonia Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Pneumonia Market Size Market Share by Region (2019-2024)
Table 29. APAC Pneumonia Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Pneumonia Market Size Market Share by Type (2019-2024)
Table 31. APAC Pneumonia Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Pneumonia Market Size Market Share by Application (2019-2024)
Table 33. Europe Pneumonia Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Pneumonia Market Size Market Share by Country (2019-2024)
Table 35. Europe Pneumonia Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Pneumonia Market Size Market Share by Type (2019-2024)
Table 37. Europe Pneumonia Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Pneumonia Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Pneumonia Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Pneumonia Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Pneumonia Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Pneumonia Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Pneumonia Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Pneumonia Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Pneumonia
Table 46. Key Market Challenges & Risks of Pneumonia
Table 47. Key Industry Trends of Pneumonia
Table 48. Global Pneumonia Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Pneumonia Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Pneumonia Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Pneumonia Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Pfizer Details, Company Type, Pneumonia Area Served and Its Competitors
Table 53. Pfizer Pneumonia Product Offered
Table 54. Pfizer Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. GlaxoSmithKline(GSK) Details, Company Type, Pneumonia Area Served and Its Competitors
Table 58. GlaxoSmithKline(GSK) Pneumonia Product Offered
Table 59. GlaxoSmithKline(GSK) Main Business
Table 60. GlaxoSmithKline(GSK) Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. GlaxoSmithKline(GSK) Latest Developments
Table 62. Merck Details, Company Type, Pneumonia Area Served and Its Competitors
Table 63. Merck Pneumonia Product Offered
Table 64. Merck Main Business
Table 65. Merck Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Merck Latest Developments
Table 67. Novartis Details, Company Type, Pneumonia Area Served and Its Competitors
Table 68. Novartis Pneumonia Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis Latest Developments
Table 72. Sanofi Details, Company Type, Pneumonia Area Served and Its Competitors
Table 73. Sanofi Pneumonia Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sanofi Latest Developments
Table 77. Eli Lilly Details, Company Type, Pneumonia Area Served and Its Competitors
Table 78. Eli Lilly Pneumonia Product Offered
Table 79. Eli Lilly Main Business
Table 80. Eli Lilly Pneumonia Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Eli Lilly Latest Developments

LIST OF FIGURES

Figure 1. Pneumonia Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pneumonia Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pneumonia Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pneumonia Sales Market Share by Country/Region (2023)
Figure 8. Pneumonia Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pneumonia Market Size Market Share by Type in 2023
Figure 10. Pneumonia in Hospitals
Figure 11. Global Pneumonia Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Pneumonia in Ambulatory Surgical Centers
Figure 13. Global Pneumonia Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Pneumonia in Others
Figure 15. Global Pneumonia Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Pneumonia Market Size Market Share by Application in 2023
Figure 17. Global Pneumonia Revenue Market Share by Player in 2023
Figure 18. Global Pneumonia Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Pneumonia Market Size 2019-2024 ($ Millions)
Figure 20. APAC Pneumonia Market Size 2019-2024 ($ Millions)
Figure 21. Europe Pneumonia Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Pneumonia Market Size 2019-2024 ($ Millions)
Figure 23. Americas Pneumonia Value Market Share by Country in 2023
Figure 24. United States Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Pneumonia Market Size Market Share by Region in 2023
Figure 29. APAC Pneumonia Market Size Market Share by Type in 2023
Figure 30. APAC Pneumonia Market Size Market Share by Application in 2023
Figure 31. China Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Pneumonia Market Size Market Share by Country in 2023
Figure 38. Europe Pneumonia Market Size Market Share by Type (2019-2024)
Figure 39. Europe Pneumonia Market Size Market Share by Application (2019-2024)
Figure 40. Germany Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Pneumonia Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Pneumonia Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Pneumonia Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Pneumonia Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Pneumonia Market Size 2025-2030 ($ Millions)
Figure 54. APAC Pneumonia Market Size 2025-2030 ($ Millions)
Figure 55. Europe Pneumonia Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Pneumonia Market Size 2025-2030 ($ Millions)
Figure 57. United States Pneumonia Market Size 2025-2030 ($ Millions)
Figure 58. Canada Pneumonia Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Pneumonia Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Pneumonia Market Size 2025-2030 ($ Millions)
Figure 61. China Pneumonia Market Size 2025-2030 ($ Millions)
Figure 62. Japan Pneumonia Market Size 2025-2030 ($ Millions)
Figure 63. Korea Pneumonia Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Pneumonia Market Size 2025-2030 ($ Millions)
Figure 65. India Pneumonia Market Size 2025-2030 ($ Millions)
Figure 66. Australia Pneumonia Market Size 2025-2030 ($ Millions)
Figure 67. Germany Pneumonia Market Size 2025-2030 ($ Millions)
Figure 68. France Pneumonia Market Size 2025-2030 ($ Millions)
Figure 69. UK Pneumonia Market Size 2025-2030 ($ Millions)
Figure 70. Italy Pneumonia Market Size 2025-2030 ($ Millions)
Figure 71. Russia Pneumonia Market Size 2025-2030 ($ Millions)
Figure 72. Spain Pneumonia Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Pneumonia Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Pneumonia Market Size 2025-2030 ($ Millions)
Figure 75. Israel Pneumonia Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Pneumonia Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Pneumonia Market Size 2025-2030 ($ Millions)
Figure 78. Global Pneumonia Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Pneumonia Market Size Market Share Forecast by Application (2025-2030)


More Publications